Table 2.
Resting and peak stress clinical and echocardiographic characteristics at baseline and follow-up in the patient
| Baseline | 5-month after pharmacological therapy |
|||
|---|---|---|---|---|
| Rest | Peak stress | Rest | Peak stress | |
| Clinical parameters | ||||
| Heart rate (bpm) | 60 | 138 | 54 | 135 |
| Systolic blood pressure (mmHg) | 136 | 184 | 118 | 176 |
| Diastolic blood pressure (mmHg) | 64 | 106 | 58 | 102 |
| Double product (mmHg/min) | 8160 | 25392 | 6372 | 23760 |
| Echocardiographic parameters | ||||
| LV end-diastolic volume (ml) | 108 | 109 | 87 | 88 |
| LV end-systolic volume (ml) | 70 | 76 | 44 | 40 |
| LV ejection fraction (%) | 35 | 30 | 49 | 54 |
| Mitral inflow pattern | impaired LV relaxation | impaired LV relaxation | normal | normal |
| E/E' | 18.9 | 19.3 | 11.4 | 10.9 |
| Radial dyssynchrony by speckle tracking strain (ms) | 45 | 260 | 42 | 48 |
E, early diastolic wave velocity; E', early diastolic mitral annular velocity; LV, left ventricular